I told my son I have cancer. He hugged me like his life depended on it
It was a warm, sunny day in the middle of June, just after 2.30 pm, and I was sitting with my wife, Marilyn, in a generically nondescript doctor's office at Whipps Cross Hospital. Having spent the previous two months undergoing tests, scans, and biopsies for suspected prostate cancer, we were almost certain the news would be bad. But no matter how prepared we thought we were to hear the words, the formal diagnosis hit us both hard.
After the initial shock, I tried to gather as much information as I could. Armed with a notepad and pen, I asked what I hoped were the right questions and tried to process what was coming back. In quick succession, Dr Chowdhury told me I had adenocarcinoma, the most common type of prostate cancer; that it was mid-stage, or stage 2, meaning it had spread beyond the prostate gland but not to the lymph nodes or beyond; and that my Gleason score was 7 (4+3), indicating a medium to high risk of the cancer spreading.
'Your cancer definitely looks treatable, but we will need to book you in for a bone scan to make sure it hasn't metastasised,' Dr Chowdhury said. 'It looks unlikely, but we need to be sure.' And if it has spread to the bones, I asked. 'That makes things more […] complicated.'
The conversation lasted only about ten minutes, yet it felt both inconsequential and monumental in equal measure. Undoubtedly, this consultation was one of many the doctor would have, but in that moment, for Marilyn and I, it meant everything. We walked to the car park in silence, then held each other tightly. After all the waiting and anticipation, we finally had the news we had feared. And now I had to face the moment I had been dreading since April – telling our children.
Despite living with the possibility of a cancer diagnosis for two months, we decided not to tell Nyah (22) and Fox (19) until we knew what we were dealing with. Nyah was living at home after graduating the previous summer, while Fox was in Durham studying for his first-year university exams, and we didn't want to distract him from his studies. We also felt it was important to break the news to them together. It was the hardest conversation I have ever had.
The day after he came home, we sat them both down, and I told them the bad news. When it came to saying the words 'I have cancer', the C-word caught in my throat. After the initial shock, we all ended up in tears. Fox hugged me like his life depended on it. At 6ft 3in and with broad shoulders, he is bigger than his old man, but at that moment he was a little boy again. I held him closer than I had in years. Then it was Nyah's turn; she buried her head in my shoulder and squeezed hard. They then both took turns cuddling Marilyn. I felt incredibly proud of them all for being so brave.
Once the initial shock had subsided, we talked. I explained the situation as best I could and tried to be as positive as possible. I didn't sugarcoat it, but I also wanted them to feel optimistic. Although the tumours in my prostate were fairly large, especially on the left side, the prognosis for stage 2 cancer is very good. Most patients, over 97 per cent, survive at least five years, and it is highly treatable. I am relatively young (56), fit, and healthy, so there was no need to panic, I reassured them.
They then asked the same question: what happens next? That was a little harder to answer. At the end of my consultation, when the doctor had informed me I had cancer, he explained that I had two options for treatment. I would have to choose between surgery to remove the prostate or radiotherapy to try to kill the cancer cells. To help make that decision, he referred me to St Bartholomew's Hospital, where I would meet specialists from both areas to discuss the best way forward.
In the meantime, while I waited for my appointment, there was the small matter of the bone scan that might just change everything…
Frequently asked questions
Answered by Prostate Cancer UK specialist nurses
1. What are the different types of prostate cancer and is there one type that's 'worse'?
Most men diagnosed with prostate cancer have a type known as adenocarcinoma. There are, however, several much rarer forms of the disease. Because these are uncommon, they have not been studied as extensively, and we know far less about them. Some of these rare cancers can be more aggressive, meaning they may grow faster and are more likely to spread to other parts of the body. In many cases, men with a rare form of prostate cancer also have some adenocarcinoma present at the same time.
Rare types of prostate cancer include:
Neuroendocrine tumours (small cell or large cell)
Glandular tumours (ductal, mucinous, or signet ring cell)
Basal cell carcinoma
Transitional cell carcinoma
Prostate sarcoma
Some of these rare cancers do not cause a rise in PSA levels. As a result, they may not be detected through a routine PSA blood test. Diagnosis may therefore only occur once the cancer has already spread outside the prostate, often following a biopsy.
2. What's a Gleason score?
After a prostate biopsy, the tissue samples are examined under a microscope by a specialist doctor called a histopathologist. They check for the presence of cancer cells and describe their findings in a pathology report.
Cancer cells in the prostate can look different depending on how likely they are to grow and spread. This appearance is given a Gleason grade, which ranges from 1 to 5. Grades 1 and 2 resemble normal prostate cells and are not usually reported. Prostate cancer is generally graded as Gleason 3, 4, or 5, the higher the number, the more aggressive the cancer is likely to be.
The Gleason score is made up of two numbers:
The most common grade seen in all the samples.
The highest other grade found in the samples.
These two numbers are added together, with the most common grade listed first. For example:
If most cancer cells are pattern 4 and the highest other pattern is 3, the score is 4+3 = 7.
A score of 3+3 = 6 usually indicates very slow-growing cancer.
A score of 7 suggests faster-growing cancer, with 4+3 generally being more aggressive than 3+4.
Scores of 8, 9, or 10 indicate faster-growing, more aggressive cancer that is more likely to spread.
3. What does it mean if cancer has metastasised?
You might hear the terms metastasised, metastatic or advanced prostate cancer. These all mean the same thing – that the cancer has spread from the prostate to other parts of the body. This occurs when cancer cells travel through the blood or lymphatic system, so the cancer is no longer contained within the prostate.
When this happens, prostate cancer is no longer curable, but treatments can be offered to help shrink the cancer and slow its growth or prevent further spread, such as hormone therapy. In recent years, research has developed a number of new treatments for advanced prostate cancer, meaning men are thankfully living longer than ever before.
Metastatic prostate cancer can sometimes cause symptoms in the areas it has affected, for example bone pain, anaemia, or issues passing urine. At this stage, additional treatments may be required to address these symptoms, rather than the cancer itself, to improve quality of life and keep the patient as comfortable as possible.
4. How should you talk to your kids about your cancer diagnosis and treatment? Is there support available for them?
Breaking the news to loved ones that you've been diagnosed with prostate cancer is never easy. It can be especially challenging when that conversation is with your children. Even when they are young adults, like Paul's children, aged 22 and 19, a parent's illness can shake their world.
Men often tell us they feel unsure about the best way to approach the conversation. While there's no single 'right' method, here are some guiding principles to help you navigate it in a way that feels true to your family, remembering that everyone approaches these conversations differently.
Choosing the right moment
Sometimes it helps to wait until you have a clear treatment plan before talking to your children. That might mean allowing time for tests and consultations to finish. Having answers ready, such as, 'This is what I have, and this is how we're going to deal with it', can make the conversation feel less uncertain for everyone.
Pick a time when you won't be interrupted, and allow space afterwards for reflection. It's common for questions to come hours or even days later, so check in with them regularly. Some men also consider what else might be happening in their children's lives – exams, travel, big events – when deciding on timing.
Considering their age and experience
The way you speak will naturally differ depending on whether your children are young, teenagers, or adults. With young adults, you might be more open about the details of diagnosis and treatment, while still tailoring your words to their emotional readiness.
If they've experienced illness in the family before, acknowledge that, but remind them that every situation is different. Above all, be honest. Children, whatever their age, often sense when something is being held back, and uncertainty can fuel anxiety. Keep them updated. Even small updates – 'I had my appointment today; they don't need to see me again for six months' – can help prevent them from imagining the worst.
Support for them, and for you
It's not just you who needs support. Your children may benefit from speaking with a counsellor, a health professional, a trusted person at school or reading information designed for family members. Organisations like Maggie's, Macmillan and Fruitfly Collective have further information on talking to children about a cancer diagnosis. Encouraging them to seek help is not a sign of weakness; it's a way of strengthening the whole family.
Facing cancer is daunting, but talking openly with your children can deepen trust, reduce fear, and help you face the journey together.
Acknowledge emotions: yours and theirs
Let them know it's OK to feel scared, angry or uncertain. Naming emotions can make them feel less overwhelming.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
22 minutes ago
- Medscape
Early Access to Weight Loss Jabs in NICE Diabetes Plan
People with type 2 diabetes (T2D) in England could be offered earlier access to newer treatments, including weight loss jabs, under draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, described as the 'biggest shake-up in care for a decade', would see a shift from a one-size-fits-all approach to a focus on personalised treatment to prevent heart failure, heart attacks, and other serious complications. Expanded Use of SGLT-2 Inhibitors The draft guidance recommends expanding access to sodium-glucose co-transporter-2 (SGLT-2) inhibitors, including canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin. Currently prescribed as a second-line option, SGLT-2 inhibitors would be available as a joint first-line treatment alongside metformin. They may also be used as monotherapy in patients intolerant to metformin. SGLT-2 inhibitors are once-daily tablets that selectively block the SGLT-2 cotransporter in the proximal renal tubule, responsible for reabsorbing about 90% of filtered glucose. This lowers the renal glucose threshold, increasing urinary glucose excretion and inducing mild osmotic diuresis. However, a 2024 NICE analysis of nearly 590,000 people with T2D in England found under-prescribing of these drugs, particularly among women, older adults, and Black patients. Only 20% of patients with atherosclerotic cardiovascular disease received SGLT-2 inhibitors, with prescribing rates declining in older age groups. NICE estimates that wider use of SGLT-2 inhibitors could save nearly 22,000 lives once uptake reaches 90%. Earlier Access to GLP-1 Agonists The draft guidance also recommends earlier use of glucagon-like peptide-1 (GLP-1) receptor agonists such as liraglutide or semaglutide. These drugs, previously reserved for later stages of disease, would be considered earlier in treatment for selected groups. NICE further supports wider adoption of digital health tools, including continuous glucose monitoring and community-based digital care. Personalised Treatment Approaches The guidance proposes tailored treatment strategies based on patient characteristics and comorbidities: Adults with cardiovascular disease should receive triple therapy (metformin, an SGLT-2 inhibitor, and a GLP-1 receptor agonist) Those with early-onset T2D (diagnosed before age 40) should receive dual therapy before considering a GLP-1 receptor agonist Patients with obesity or chronic kidney disease should have specific combinations based on their condition and kidney function, respectively. Adults with clinical frailty should start with metformin monotherapy. Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE, said the draft guidance marks a 'significant evolution' in diabetes care. 'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes, and other serious complications before they occur,' he said. Burden of Diabetes in the UK Approximately 4.6 million people in the UK have diabetes, with 90% diagnosed with T2D. Diabetes UK estimates that a further 1.3 million may be undiagnosed. The condition costs the NHS £1 million per hour, with 60% of spending linked to complications. Each week, diabetes contributes to more than 930 strokes, 660 heart attacks, and nearly 2990 cases of heart failure. Douglas Twenefour, head of clinical at Diabetes UK, welcomed the draft guidance. 'The majority of people with T2D are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications,' he said. 'Tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease.' Waqaar Shah, a GP partner at Chatfield Health Care in London and chair of the NICE guideline committee, said that these recommendations 'could help reduce health inequalities while providing better outcomes for everyone'. Implementation and Safety The draft guidance remains open for public consultation until 2 October. NICE will review feedback before publishing final recommendations. The guidance aims to promote equitable access to recommended therapies, supported by local training initiatives. Healthcare professionals have also stressed the need for safe prescribing of SGLT-2 inhibitors, which carry risks including diabetic ketoacidosis (DKA). Before starting treatment, providers should assess whether patients have previously experienced DKA, have acute illness, or follow very low-carbohydrate or ketogenic diets.
Yahoo
an hour ago
- Yahoo
UK Food Safety Testing Market Size to Reach US$2.8 Billion by 2033
Shaped by strict Food Standards Agency (FSA) regulations and post-Brexit import complexities, the UK market emphasizes robust allergen management and supply chain traceability. High consumer awareness and advanced rapid testing methods are integral to maintaining confidence. Chicago, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The UK food safety testing market was valued at US$ 1,306.23 million in 2024 and is expected to reach US$ 2,801.82 million by 2033, growing at a CAGR of 9.23% during the forecast period 2025–2033. A dramatic surge in foodborne pathogens is a primary catalyst for growth. The frequency and scale of recent outbreaks are alarming. Official data show 70,352 laboratory-confirmed cases of Campylobacter in England during 2024, marking a decade-long high. Similarly, Salmonella infections in England peaked at 10,388 reported cases in 2024. Specific outbreaks highlight the severity of the situation. A 2024 Salmonella Blockley event resulted in 54 cases across the UK. These cases were distributed with 36 in England, 11 in Scotland, and 7 in Wales. The outbreak led to the hospitalization of ten individuals. Download Sample Pages: Even more concerning was a major Shiga toxin-producing E. coli (STEC) O145 outbreak in summer 2024, which caused over 250 illnesses in the UK food safety testing market. By late June 2024, confirmed cases reached 275. The geographical breakdown shows 182 cases in England, 58 in Scotland, and 31 in Wales. The outbreak's severity is underscored by the 122 people hospitalized. Furthermore, seven confirmed cases of haemolytic uraemic syndrome (HUS) were directly linked to the STEC O145 event. The Food Standards Agency (FSA) is actively investigating an increased number of incidents. Investigations into Listeria-related outbreaks grew to 17 in the 2024/25 period. STEC-related outbreak investigations rose to 13, and Salmonella outbreak investigations increased to 11 in the same timeframe. Adding to the domestic pressure, 2,703 cases of travel-associated gastrointestinal infections were recorded in England in 2024, with 183 of these being travel-related STEC infections. Key Findings in UK Food Safety Testing Market Market Forecast (2033) US$ 2,801.82 million CAGR 9.23% By Test Method Microbiological Test (36.64%) By Product Type Processed Food (25.56%) By Containment Type Biological Contaminants (36.85%) By Technology Traditional Testing (54.63%) By Service Sourcing Inhouse (57.75%) By Application Pathogen Detection (44.03%) By End User Food & Beverage (66.6%) Top Drivers Stringent post-Brexit import controls require comprehensive testing regimes. High consumer demand for transparency and clean-label products. Growth of plant-based and free-from food categories necessitates testing. Top Trends Adoption of whole-genome sequencing for precise outbreak source tracking. Focus on developing rapid tests for emerging environmental contaminants. Increased use of data analytics for predictive risk modeling. Top Challenges Navigating regulatory divergence between the UK and the EU. Persistent labor shortages impacting food industry and laboratory staffing. Combatting sophisticated food fraud and economically motivated adulteration. Chemical Contaminant Risks Mandate Broader and More Sophisticated Testing Protocols The threat is not limited to pathogens; chemical contaminants demand equal attention in the UK food safety testing market. Growing concerns over pesticides, industrial chemicals, and mycotoxins are expanding the required scope of testing services. In 2024, the FSA issued 14 food alerts for metal contamination alone, with 4 of these occurring by April. Analysis of imported food revealed residues of 48 pesticides not approved for use in the UK. A deeper look found residues from 46 cancer-linked pesticides in imported produce. In comparison, 19 cancer-linked pesticides were detected in food originating from the UK in 2024. The issue of "forever chemicals" has become prominent. A 2024 analysis discovered 10 different PFAS pesticides in fruit and vegetables sold in the UK food safety testing market. The nation currently approves 25 PFAS pesticides for use, with 6 of them classified as 'highly hazardous'. Government testing confirmed the presence of PFAS chemicals in over 3,300 food and drink samples in 2024. These findings came from a program that tested approximately 3,000 samples of food and produce. Meanwhile, the UK's annual testing for heavy metals covers a mere 400 to 450 samples of meat, milk, fish, and honey. A potential source of contamination is the UK's over 8,500 abandoned mines, which can leach toxic metals into the food chain. Specific food surveys also raise red flags. In a 2024 retail food survey, 13 out of 30 soy samples tested contained elevated levels of the mycotoxin ochratoxin A. A separate test of 90 samples for physical contaminants found one sample to be non-compliant. Escalating Product Recalls and Allergy Alerts Underscore Critical Testing Needs The sheer volume of product recalls provides a stark indicator of systemic weaknesses. These events in the UK food safety testing market are not only more frequent but also larger in scale, fuelling investment in preventive testing. In 2024, just three large-scale recall alerts implicated a staggering 424 different products. The average number of products recalled per event in 2024 was 2.5 times higher than in 2023. In the 2023/24 period, the FSA and Food Standards Scotland (FSS) issued a combined total of 136 food alerts. Within that total, 66 were specific Allergy Alerts. The focus on allergens intensified significantly, with 101 Allergy Alerts issued by the FSA and FSS in 2024. Beyond allergens, there were 67 product recalls in 2024 due to issues like foreign bodies and microbial contamination. The problem is widespread. In the first quarter of 2025, a total of 1,242 food and beverage recalls were recorded across the EU and UK. Non-bacterial contamination was responsible for 550 of these recalls. Aflatoxins were the culprit in 135 recall events. Bacterial contamination led to 237 recalls, with Salmonella being the cause of 174 of those incidents. Undeclared allergens prompted 94 recalls in Q1 2025, with milk being the most frequent issue, causing 19 separate recalls. Such figures make a compelling case for the expanding UK food safety testing market. Strict Regulatory Enforcement and Incident Management Spur Compliance-Driven Testing Demand Regulatory bodies are intensifying their oversight, making robust testing a non-negotiable aspect of compliance. The FSA's incidents response unit managed 1,837 food and feed incidents in the 2023/24 financial year. In the subsequent 2024/25 period, the FSA received notifications for 1,825 incidents across England, Wales, and Northern Ireland. Beyond direct notifications, the agency monitored 12,504 food safety signals in 2024/25. These signals prompted 810 intelligence assessments, which in turn launched 36 new investigations. Ultimately, these monitored signals resulted in 18 new incidents that required product withdrawal from the market. Local authorities are also increasing formal enforcement actions, which rose to 5,898 for food hygiene in 2023/24. Actions related to food standards in the food safety testing market grew to 658 in the same period. The financial consequences of non-compliance are severe. In a high-profile 2024 case, retailer ASDA was fined £640,000 for selling over 100 out-of-date food items. Asda was also ordered to pay an additional £15,115 in prosecution costs. The case was not an isolated one; it followed two other 2024 instances where Asda was fined £250,000 and £410,000 for similar food safety breaches. These penalties send a clear message to the industry. Specialized Food Crime and Fraud Investigations Are Now Major Market Drivers A growing area of focus is the criminal threat to the food supply chain. Specialized units are actively tackling food fraud, creating a niche for advanced authenticity and integrity testing. The UK's food crime units were running 29 live investigations during 2024. A significant portion of these, 20 investigations, involved meat and meat products. The scale of these operations is considerable. In a single food crime case in November 2024, officers seized 48 illegal sheep carcasses. As part of that National Food Crime Unit (NFCU) investigation into illegal meat, five men were arrested in London. The NFCU is also securing financial penalties against perpetrators. In a 2025 case, the unit obtained a confiscation order of over £30,000 from an individual selling illegal 'smokie' meat products. The action marked the third high-profile 'smokie' meat fraud case pursued by the NFCU within a single year. These enforcement successes highlight the critical need for sophisticated testing solutions that can verify the origin, composition, and legality of food products, a key growth area for the UK food safety testing market. Strained Local Authority Resources Create Significant Gaps in Public Food Safety While regulatory demands are increasing, the capacity of public enforcement bodies is strained. Under-resourced local authorities in the UK food safety testing market are struggling to maintain oversight, shifting a greater burden of responsibility onto businesses and their internal testing programs. As of 2024, there is a backlog of 95,000 overdue food business inspections across England, Wales, and Northern Ireland. Worryingly, this backlog includes 871 businesses classified as high-risk. In Scotland, 12,533 registered food businesses remained unrated as of December 2024. The number of unrated establishments awaiting a first inspection in England, Wales, and Northern Ireland had grown to around 41,000 by April 2024. This resource strain is directly impacting surveillance. The total number of food samples taken by local authorities across the UK dropped to 37,911 in the 2023/24 period. This figure is down from 40,144 samples in the prior period, showing a continuing decline in public testing capacity. Concurrently, consumer complaints are rising. There was an increase of 1,540 consumer complaints related to food hygiene in 2023/24, reaching a total of 60,919. Complaints regarding food standards and authenticity also rose by 200, to a total of 11,188 in the same period. Competitive Landscape Heats Up as Key Players Expand to Meet Demands Leading providers in the UK food safety testing market are responding to these challenges with strategic expansions and innovations. Key players are enhancing their capabilities to capture growing demand, particularly in identified hotspot sectors. In July 2025, Eurofins Food Testing UK demonstrated a clear growth strategy by finalizing its acquisition of the Bio Search food testing laboratory in Belfast. The move significantly expands its capabilities and footprint in Northern Ireland. In 2024, Eurofins also launched a new method for enumerating acetic acid bacteria, a service specifically targeting the needs of the UK beverage industry. These expansions are timely, as certain food categories are under intense scrutiny. A 2024 FSA survey found that 16 out of 40 samples of frozen raw chicken, a total of 40%, were non-compliant due to issues like undeclared water. The same survey revealed that 10 out of 24 frozen beef burger samples, or 42%, were non-compliant. Among the non-compliant burger samples, eight were found to have less meat content than what was declared on the label. These sector-specific failings create clear opportunities for specialized testing services. Advanced Whole Genome Sequencing Technology Revolutionizes Outbreak Response and Investigation The evolution of the UK food safety testing market is intrinsically linked to technological advancement. While widespread adoption rates are proprietary, official reports confirm the critical role of next-generation methods. Advanced testing technologies, particularly whole genome sequencing (WGS), are no longer on the horizon; they are central to modern surveillance and response. The UK Health Security Agency (UKHSA) extensively used WGS to successfully identify and manage the 2024 outbreaks of Salmonella Blockley and E. coli O145. The application of WGS in these high-profile incidents demonstrates the technology's power. It allows for a level of precision in linking cases and identifying the source of an outbreak that was previously impossible. This capability is transforming public health investigations. The clear success and growing reliance on WGS signal a market-wide shift. The move is away from traditional culturing methods and toward more rapid, accurate, and data-rich technologies. This technological pivot is a fundamental driver of investment and innovation across the entire food safety sector. Need a Customized Version? Request It Now: Post-Brexit Regulations and Future Trends Shaping the UK Food Safety Market The future of the UK food safety testing market will be shaped by an evolving regulatory framework and the continuation of current trends. Post-Brexit adjustments are creating new compliance hurdles and, consequently, new testing requirements. As of January 1, 2024, a significant new rule took effect. All pre-packaged food sold in Great Britain must now include a UK address for the Food Business Operator. The change introduces new labeling verification needs for the entire industry. Looking ahead, the market's growth trajectory appears strong and certain. The convergence of the key drivers—relentless pathogen pressure, expanding chemical threats, massive product recalls, tough enforcement, and public sector gaps—creates a compelling case for sustained investment. Businesses have no alternative but to integrate more frequent, more sophisticated, and more comprehensive testing into their operations. The demand is not just for testing, but for a true partnership in risk mitigation, making the UK food safety testing market a critical component of national food security and public health for years to come. UK Food Safety Testing Market Major Players: ALS Laboratories (UK) Limited Bureau Veritas UK Limited Campden BRI Group Eurofins Food Testing UK Limited Fera Science Limited Food Forensics Limited Intertek Group Plc. Northern Hygiene Laboratories Limited SGS United Kingdom Limited TÜV SÜD UK Limited Other Prominent Players Key Market Segmentation: By Test Method Microbiological Test Total Plate Count (TPC) Coliform Testing Listeria Testing Salmonella Testing Campylobacter Testing Sensory Test Manual Smell Taste Appearance Others Instrumental Smell Taste Appearance Others Physical Test Chemical Test Allergen Test Others By Product Type Processed Food Fruits &Vegetables Beverages Grains & Cereal Confectionery Meat & Meat Products Milk & Milk Products Others By Technology Traditional Testing Rapid Testing By Service Sourcing Inhouse Outsource By End User Food & Beverage Academic and Research Institutions Testing Laboratories Need a Detailed Walkthrough of the Report? Request a Live Session: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:


Forbes
an hour ago
- Forbes
4 Reasons Why ‘Self-Blame' Is Your Default State, By A Psychologist
The habit of staying up at night and replaying all the embarrassing moments of your life while stewing in self-blame isn't just a personality quirk. For most people, this recurring phenomenon, often beyond their control, can start feeling like a mental trap where you keep turning thoughts like 'you should have known better' over and over again in your head. This can also disrupt your sleep cycle. A 2022 study published in the British Journal of Clinical Psychology found that people most often ruminate or worry about past mistakes, negative experiences and social interactions, with nighttime being a high-risk period for such overthinking. The reason you stay stuck in this cycle has to do with your mind's tendency to disguise rumination as 'problem-solving.' You might be under the impression that you're figuring out what went wrong or making sure you will not repeat the mistake. However, in reality, you're just reinforcing the guilt and trapping yourself even further in the same emotional cycle. Over time, this habit can end up chipping away at your confidence, relationships and most importantly, your sense of self. A 2025 study published in Self and Identity explored why forgiving yourself is so difficult for some people and why they can be stuck in self-condemnation. Out of 80 participants, researchers found that 41 of them said they couldn't forgive themselves after a perceived failure. For 39 of them, self-forgiveness came easier. Researchers also identified key patterns that keep people trapped in such self-blame. Here are four reasons you're stuck in a mindset of self-blame, based on the 2025 study: 1. Your 'Time Focus' Keeps You Stuck One of the patterns researchers uncovered through the study was a difference in time focus. People unable to forgive themselves tended to experience the past as if it were still the present. This showed up in many ways. They replayed mistakes in vivid detail and reimagined what they 'should have done.' Essentially, they emotionally relived the moment repeatedly, and painstakingly. The researchers described this as a 'past-as-present' mindset. 'It is a raw feeling. Just like it happened yesterday, but I moved my daughter 4 years ago,' one participant explains, remembering how she struggled to forgive herself when she found out her daughter was being bullied in school. In sharp contrast, the group that could more easily forgive themselves showed a 'future-focused' perspective. They acknowledged their mistake and redirected their attention toward growth, how they could change and what the next steps could be, rather than staying shackled to what had already happened. 'I needed to forgive myself so I could stop blaming myself and stop looking toward the past when I needed to be looking toward the future,' another participant explains, highlighting the power of a future-focus in finding self-forgiveness. These findings suggest that when your dominant focus is on the past, it becomes hard to even see the possibility of a different future. When you find yourself ruminating on the past, you may start to feel like this is an unchangeable part of who you are. But it helps to remember that you are not frozen in that moment. Being in the present moment gives you the power to decide what comes next and take actions that can bring about real change. 2. You Doubt Your Own Agency Moving on from your mistakes isn't just about where your attention is. An important factor we often ignore is our belief in our own ability to make things different. The 2025 study found that people who struggled to forgive themselves frequently questioned whether they even had the ability to change the situation or prevent it from happening again. This 'low-agency' mindset left them feeling powerless. Participants who found themselves stuck in self-condemnation harped on their lack of control over their behavior or circumstances. This led to a deepening of their guilt. On the other hand, those who forgave themselves believed they still had agency. They believed in their capacity to make choices and influence life outcomes. This belief allowed them to move forward. If you lack a sense of agency, it's quite possible your mind lingers on your mistakes, negative events and the past as a prediction of your future. Rebuilding self-trust, therefore, is the first order of business. And you're allowed to start small, such as keeping a promise to yourself, showing up on time to a commitment you've made or making one healthier choice than the day before. 3. You See Your Mistakes As A Reflection Of Your Entire Character Often, the heaviest part of self-blame isn't the action itself. It's what you believe that action says about you that can determine how you see yourself. The researchers of the 2025 study found that people trapped in self-condemnation often saw their mistakes as a reflection of their social-moral identity, or their sense of being a 'good' or 'bad' person in their own eyes and the eyes of others. So, instead of viewing their wrongdoing as a single or isolated event, they saw it as proof that they were fundamentally flawed or unworthy. 'I have a particularly bad habit that has developed over many years. I have tried many times to break the habit without success. This is something I should be able to choose not to do, yet I keep doing it. I cannot forgive myself for developing the habit, and I cannot forgive myself for failing to break the habit. It's demoralizing, frustrating, and has ruined my self-esteem,' one participant shares. However, people who managed to forgive themselves were more likely to separate what they did from who they are. They acknowledged the harm but didn't let it define their whole identity. Moving forward can feel like a moral battle when your self-image feels tied to every misstep. 4. You Cope By Avoiding Instead Of Processing When you're drowning in deep guilt or regret, a natural instinct to quiet the discomfort might kick-in. This can happen in different ways for everyone, say binge-watching something, scrolling endlessly, overworking or distracting yourself in other ways. Indulging in these distractions can numb the emotions for a while, but that might not always be a solution for the long term. Researchers found correlations between self-condemnation and this 'emotion-reduction' style of coping. The defining characteristic of this style was pushing away uncomfortable feelings and a steadfast avoidance of processing and working through them. While this silences short-term pain, it leaves the root cause untouched, with guilt floating just beneath the surface. On the other hand, making sense of a certain event or feeling helps give it a proper ending in your mind. You reflect on what you've learned, have a compassionate conversation with yourself or reframe the event as part of your growth. For instance, one participant mentioned, 'In order to be the best parent I could be, I had to forgive myself and focus on my daughter. I just had to make myself understand that there were many factors that contributed to my daughter's depression, and I was not solely to blame.' Keep in mind that while you cannot change the past, you certainly can change the role it plays in your story and determine how it impacts you and your life. Mistakes Are Proof That You Tried To truly break free from self-blame, you need to make a shift in the relationship you have with that moment frozen in time. Your mistakes do not vanish, no matter how much you try. The good news is, they don't have to. When you learn to approach them from a growth perspective, you can see them as separate from yourself and they become catalysts for insight and resilience. An easy way to shift your perspective is using a narrative reframing technique for your past. Instead of just trying to push guilt away or analyze your mistake, you can go back to the memory and forage for moments of growth and perseverance. Done enough times, you'll likely notice that the emotions you associate with the mistake have taken a 180 degree turn for the positive. Do you keep replaying your mistakes in your mind? Take the science-backed Mistake Rumination Scale to learn more about this habit.